R&D News | pharmaphorum

News

Lab software firm Benchling sheds staff

Benchling has seen its business grow at a healthy lick since it launched in 2012 with a mission to improve the efficiency of the biopharma R&D process, but it looks li

News

ZS mourns death of co-founder Andy Zoltners

The biopharma industry has lost another leading figure with the passing of Andy Zoltners, co-founder of ZS Associates, on the 40th anniversary of the company.

News

BMS goes down the Tubulis route for cancer ADCs

Bristol-Myers Squibb has formed another alliance focusing on antibody-drug conjugates (ADCs) for solid tumours, paying German biotech Tubulis $22.75 million upfront to get

News

Moderna tags IBM for quantum leap in mRNA research

Moderna and IBM have formed a partnership to see how cutting-edge technologies like generative artificial intelligence and quantum computing could be applied to the discov

News

Leaked data shows stellar efficacy for J&J’s Carvykti

Johnson & Johnson was preparing to divulge the data from its eagerly-awaited CARTITUDE-4 trial of CAR-T therapy Carvykti later this year, but a leak of the data has gi

News

Gilde wraps up fresh health investment fund worth €600m

Netherlands-based investment group Gilde Healthcare has raised €600 million ($658 million) for a new transatlantic fund intended to support innovative ventures in digital

Lab software firm Benchling sheds staff

ZS mourns death of co-founder Andy Zoltners

BMS goes down the Tubulis route for cancer ADCs

Moderna tags IBM for quantum leap in mRNA research

Leaked data shows stellar efficacy for J&J’s Carvykti

Gilde wraps up fresh health investment fund worth €600m

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks